Skin graft rejection by beta 2-microglobulin-deficient mice.
about
A novel receptor on allograft (H-2d)-induced macrophage (H-2b) toward an allogeneic major histocompatibility complex class I molecule, H-2Dd, in mice.Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.New directions in natural killer cell-based immunotherapy of human cancer.Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice.Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient miceMice lacking major histocompatibility complex class I and class II molecules.Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapyAntiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene.Divergence between cytotoxic effector function and tumor necrosis factor alpha production for inflammatory CD4+ T cells from mice with Sendai virus pneumonia.CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion.Roles and mechanism of natural killer cells in clinical and experimental transplantation.Natural killer cells in rejection and tolerance of solid organ allograftsInnate immunity in transplant tolerance and rejection.The innate immune system in transplantation.Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors.Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL.Recognition of the major histocompatibility complex restriction element modulates CD8(+) T cell specificity and compensates for loss of T cell receptor contacts with the specific peptideKIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection.The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes.Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.Down-regulated expression of monocyte/macrophage major histocompatibility complex receptors in human and mouse monocytes by expression of their ligands.Autoreactivity to self H-2Kb peptides in TAP1 mice. Intravenous administration of H-2Kb class I-derived peptides induces long-term survival of grafts from C57BL/6 donors.
P2860
Q33234400-3E9DDF6C-0272-48EE-ACD0-36CE1BEB8B1EQ34103866-A5680657-36C5-4C36-A6D6-7A7088B563F2Q35093608-F2555A3C-F7A1-4785-9554-94EE7007D0EDQ35454753-1985E60A-94FD-475B-9FFC-8EA7937153DAQ35580258-73F7EE1A-1C5D-4E35-9165-35EA38619A9CQ35982359-7E5B45DC-BDC2-4682-B816-2F32BCA83288Q36202548-7BB417D9-E51D-4635-8D2F-D252C1BD1352Q36271130-CA0C61DF-F380-4B7D-96FA-8AFDF3250394Q36470726-3644C286-8E32-42D5-A05E-556F393EFCB2Q36639479-FBD32AB8-35E5-4326-9C26-0887481FD1D1Q36653976-809A9E7C-1CD9-446D-8DCA-561698FE4E0EQ37331884-FA94BE57-DB8E-4300-A423-D8DF97FCBB28Q37755212-CAC6FC7F-F47D-401D-AD20-7CA52B34B216Q37820879-754D4DE7-D85F-4091-BA81-B09B00ADA91CQ37864689-8447F8C5-4357-4026-BCCA-72D99F578B20Q37896918-B2C87994-3371-4E38-8D9B-11AA348B4DE5Q40317427-ED47B5DD-21F6-4424-AAE6-C815567344F3Q40597206-DF1A1C53-B9EB-4CB0-AF55-95FE6A87E8D9Q40967335-D7BA809D-ED6E-42B0-AFBC-67D9332A05B2Q41985731-9F77DE7C-1525-4A4F-9541-58EEDB194753Q42380589-4B407585-BCA7-43FA-B871-4DF4AA0E9258Q42942183-3F6FBB0B-C4BA-4601-A184-13EDBBC7ED1FQ45884830-2A7A6CD6-055E-4EF1-8D8F-9AC2400A75CEQ47901946-3FA28ACA-C3BA-49BB-94A6-D5D4A2A20063Q50456082-EBBF1B2E-5793-4581-8B67-40A717F8452DQ53666747-A74858FF-83F5-43F9-8236-D15FFA1BED8A
P2860
Skin graft rejection by beta 2-microglobulin-deficient mice.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Skin graft rejection by beta 2-microglobulin-deficient mice.
@ast
Skin graft rejection by beta 2-microglobulin-deficient mice.
@en
type
label
Skin graft rejection by beta 2-microglobulin-deficient mice.
@ast
Skin graft rejection by beta 2-microglobulin-deficient mice.
@en
prefLabel
Skin graft rejection by beta 2-microglobulin-deficient mice.
@ast
Skin graft rejection by beta 2-microglobulin-deficient mice.
@en
P2093
P2860
P356
P1476
Skin graft rejection by beta 2-microglobulin-deficient mice.
@en
P2093
H Auchincloss
J M Loring
M Zijlstra
P S Russell
R Jaenisch
P2860
P304
P356
10.1084/JEM.175.4.885
P407
P577
1992-04-01T00:00:00Z